Company Description
Focused on developing novel formulations of traditional and psychedelic therapeutics Silo Pharma Inc. is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Through the acquisition and licensing of technology rights and IP from leading universities and researchers, Silo focuses on developing novel therapies that are conventional drugs and psychedelic formulations.